November 3, 2025
1 min read

Blood Pressure Medication, Prazosin, Recalled Over Cancer Risk

MONDAY, Nov. 3, 2025 The U.S. Food and Drug Administration (FDA) has recalled over half a million bottles of a widely prescribed blood pressure medication, praz

Leave a Reply

Your email address will not be published.

Previous Story

FDA Warns Against Fluoride Tablets for Young Children

Next Story

5,000 steps a day could slow cognitive decline in people with signs of Alzheimer’s, study suggests

Previous Story

FDA Warns Against Fluoride Tablets for Young Children

Next Story

5,000 steps a day could slow cognitive decline in people with signs of Alzheimer’s, study suggests

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader

STAT+: A new attack on AMA’s billing codes

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Brain
Go toTop